Portugal – Pharmaceutical products – aquisição do medicamento Axicabtagene ciloleucel 0.4 - 2 x10e8 células Disp inj Fr
Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E. awarded €1.5M to Imprensa Nacional-Casa da Moeda, S. A. (INCM) for Construction & Public Works in April 2025 — one of 76 awards this buyer has made, above its typical award size.
Winning supplier
Imprensa Nacional-Casa da Moeda, S. A. (INCM)Contract description
Portugal – Pharmaceutical products – aquisição do medicamento Axicabtagene ciloleucel 0.4 - 2 x10e8 células Disp inj Fr 68 ml IV
Related awards · Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E.
76 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-36982-2026Getinge Group Portugal Unipessoal Lda€349M19 Jan 2026 Construction
- ocds-ted-236115-2026IBA, Ion Beam Applications, S.A.€53.0M07 Apr 2026 Construction
- ocds-ted-294579-2025Varian Medical Systems Iberica S.L.€10.6M07 May 2025 Construction
Other wins · Imprensa Nacional-Casa da Moeda, S. A. (INCM)
93 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-430956-2026Estrutura de Missão «Recuperar Portugal»€699M24 Jun 2026 Professional Services
- ocds-ted-197564-2026Município de Viana do Castelo€69.7M23 Mar 2026 Construction
- ocds-ted-698275-2025Município de Viana do Castelo€6.5M23 Oct 2025 Professional Services
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E. and Imprensa Nacional-Casa da Moeda, S. A. (INCM) — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back